ANTIHYPERGLYCEMIC ACTIVITY OF PITHECELLOBIUM DULES PLANT EXTRACTS ON BLOOD GLUCOSE LEVELS OF STREPTOZOCIN-INDUCED DIABETIC RATS
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2018, Vol 8, Issue 2
Abstract
Background: The prevalence of diabetes mellitus continues to rise worldwide and treatment with oral hypoglycemic drugs leads to numerous side effects and huge monetary expenditure. Therefore active research on identification of new antidiabetic drugs with minimal side effects from medicinal plants is a challenge according to WHO recommendations. In this aspect, the present study was undertaken to evaluate the antihyperglycemic potential of Pithecellobium dules plant in streptozotocin (STZ) induced diabetic rats. Methods: Diabetes was induced in male wister rats by intraperitoneal administration of STZ (45 mg/kg.b.w).Fasting blood glucose (FBG) levels were measured by glucose-oxidase & peroxidase method. The statistical analysis of results was carried out using and one-way analysis (ANOVA) followed by Student t-test. Results and Discussion: Antihyperglycemic potentials of plant of Pithecellobium dules extract has been investigated at the doses of 150, 300 and 600 mg/kg body weight orally administered to streptozocin-induced diabetes male wistar rats. Treatment of streptozocin diabetic male wistar rats with the extracts caused a significant (P<0.01) reduction in the blood glucose levels. The highest activity resides at the dose of 600 mg/kg body weight with mean percentage blood glucose level change of 55.32% after 6 hours of extract administration while the other two doses 150 and 300 mg/kg have blood glucose level change of 40.45% and 47.14% respectively after 6 hours of extract administration. This result suggests that the Pithecellobium dules plant extracts possess antihyperglycemic effect on streptozocin-induced diabetic male wistar rats. Conclusions: The plant extract is capable of managing antihyperglycemia and complications of diabetes in STZ induced diabetic rats. Hence, this plant may be considered as one of the potential sources for the isolation of new oral anti hypoglycemic agent(s) Keywords: Antihyperglycemic activity, Streptozocin, Pithecellobium dules, Diabetes mellitus
PLGA NANOMEDICINE
Poly lactic-co-glycolic acid (PLGA) based nanoparticles are wildly used for the delivery of bioactive compounds such as dexamethasone, curcumin, azithromycin, doxorubicin and indocyanine green. It was found that those po...
Combined use of DSC, TGA, XDR and NIR in the compatibility study of preformulation mixtures for the development of 10 mg tablets of Rupatadine Fumarate
It is essential to guarantee physico-chemical compatibility between the active pharmaceutical ingredient (API) and the components that are planned to be used in the development of a pharmaceutical formulation. A successf...
CONSUMER ADVERSE DRUG REACTIONS (ADRS) REPORTING IN MALAYSIA: A RETROSPECTIVE ANALYSIS OF SPONTANEOUS REPORTS FROM THE NATIONAL PHARMACOVIGILANCE DATABASE FROM 2008 TO 2015
Many countries are incorporating direct patient reporting of adverse drug reactions (ADRs) into their pharmacovigilance systems as patients provide a different insight into drug safety compared to healthcare professional...
EFFECT OF PARTHENIUM HYSTEROPHORUS ON OXIDATIVE STRESS IN PANCREATIC TISSUE OF DIABETIC RATS
Increased oxidative stress and decreased endogenous antioxidant defense has been shown to be a prominent and early features in diabetes mellitus. The present study focused on investigating the possible protective role of...
FORMULATION OF PACLITAXEL LOADED NANOSTRUCTURED LIPID CARRIERS TO STUDY THE EFFECT OF CONCENTRATION OF LIQUID LIPIDS ON DRUG RELEASE
In the present study, stearic acid (SA) nanostuctured lipid carriers (NLC) with different proportions of oleic acid (OA) were successfully prepared by solvent diffusion method in an aqueous system. OA was taken in the co...